Calpain regulates actin remodeling during cell spreading

Journal of Cell Biology

Volumn 141, Issue 3, 1998, Pages 647-662

  Potter, David A ^a,b,h   Tirnauer, Jennifer S ^a,e   Janssen, Richard ^a,f   Croall, Dorothy E ^c   Hughes, Christina N ^a,g   Fiacco, Kerry A ^a   Mier, James W ^a,f   Maki, Masatoshi ^d   Herman, Ira M ^b  

^a Tupper Research Institute   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MAINE   (United States)

^d NAGOYA UNIVERSITY   (Japan)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g LEWIN GROUP   (United States)

^h TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIUM ION; CALPAIN; CALPASTATIN; CALPEPTIN; EZRIN; FOCAL ADHESION KINASE; FODRIN; MOESIN; PROTEIN KINASE C ALPHA; RADIXIN; TALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ISOLATION; ENZYME REGULATION; GENE OVEREXPRESSION; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

3T3 CELLS; ACTINS; ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; CELL MOVEMENT; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETAL PROTEINS; DOWN-REGULATION; HUMANS; MICE; PHOSPHOPROTEINS; SUBSTRATE SPECIFICITY; UP-REGULATION;

EID: 0032482239     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.141.3.647     Document Type: Article

References (82)

1. Algrain, M., O. Turunen, A. Vaheri, D. Louvard, and M. Arpin. 1993. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeleton linker. J. Cell Biol. 120:129-139.
2. Anagli, J., J. Hagmann, and E. Shaw. 1991. Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors. Biochem. J. 274:497-502.
3. 2+-activated neutral proteinase (calpain) in intact human platelets. Biochem. J. 289: 93-99.
4. Anagli, J., E.M. Vilei, M. Molinari, S. Calderara, and E. Carafoli. 1996. Purification of active calpain by affinity chromatography on an immobilized peptide inhibitor. Eur. J. Biochem. 241:948-954.
5. Angliker, H., J. Anagli, and E. Shaw. 1992. Inactivation of calpain by peptidyl fluoromethyl ketones. J. Med. Chem. 35:216-220.
6. Asada, K., Y. Ishino, M. Shimada, T. Shimojo, M. Endo, F. Kimizuka, I. Kato, M. Maki, M. Hatanaka, and T. Murachi. 1989. cDNA cloning of human calpastatin: Sequence homology among human, pig, and rabbit calpastatins. J. Enzyme Inhib. 3:49-56.
7. Barnoy, S., T. Glasner, and N.S. Kosower. 1996. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Comm. 220:933-938.
8. Bassell, G.J., H. Zhang, A.L. Byrd, A.M. Femino, R.H. Singer, K.L. Taneja, L.M. Lifshitz, I.M. Herman, and K.S. Kosik. 1998. Sorting of beta-actin mRNA and protein to neuntes and growth cones in culture. J. Neurosci. 18: 251-265.
9. Beckerle, M.C., K. Burridge, G.N. DeMartino, and D.E. Croall. 1987. Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion. Cell. 51:569-577.
10. Bronk, S.F., and G.J. Gores. 1993. pH-dependent nonlysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes. Am. J. Physiol. 264: G744-G751.
11. Brundage, R., K. Fogarty, R. Tuft, and F. Fay. 1991. Calcium gradients underlying polarization and chemotaxis of eosinophils. Science. 254:703-706.
12. Chomczinski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
13. Cooray, P., Y. Yuan, S.M. Schoenwaelder, C.A. Mitchell, H.H. Salem, and S.P. Jackson. 1996. Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain. Biochem. J. 318:41-47.
14. Crawford, C. 1990. Protein and Peptide Inhibitors of Calpains. In Intracellular Calcium-dependent Proteolysis. R.L. Mellgren and T. Murachi, editors. CRC Press. Boca Raton, FL. 75-89.
15. Crawford, C., R.W. Mason, P. Wikstrom, and E. Shaw. 1988. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. Biochem. J. 253:751-758.
16. Crepaldi, T., A. Gautreau, P.M. Comoglio, D. Louvard, and M. Arpin. 1997. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138:423-434.
17. Croall, D.E., and G.N. DeMartino. 1991. Calcium-activated neutral protease (calpain) system: Structure, function, and regulation. Physiol. Rev. 71:813-847.
18. Croall, D.E., and K.S. McGrody. 1994. Domain structure of calpain: Mapping the binding site for calpastatin. Biochemistry. 33:13223-13230.
19. Croall, D.E., C.A. Slaughter, H.S. Wortham, CM. Skelly, L. DeOgny, and C.R. Moomaw. 1992. Polyclonal antisera specific for the proenzyme form of each calpain. Biochim. Biophys. Acta. 1121:47-53.
20. Cunningham, C.C., T.P. Stossel, and D.J. Kwiatkowski. 1991. Enhanced motility in NIH-3T3 fibroblasts that overexpress gelsolin. Science. 251:1233-1236.
21. DeMartino, G.N., C.A. Huff, and D.E. Croall. 1986. Autoproteolysis of the small subunit of calcium-dependent protease II activates and regulates protease activity. J. Biol. Chem. 261:12047-12052.
22. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nuc. Acids Res. 11:1475-1489.
23. Feinberg, A.P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
24. Gary, R., and A. Bretscher. 1993. Heterotypic and homolypic associations between ezrin and moesin, two putative membrane-cytoskeletal linking proteins. Proc. Natl. Acad. Sci. USA. 90:10846-10850.
25. Gary, R., and A. Bretscher. 1995. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol. Biol. Cell. 6:1061-1075.
26. Glaser, T., and N.S. Kosower. 1986. Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor (calpain-calpastatin) balance. FEBS (Fed. Eur. Biochem. Soc.) Lett. 206:115-120.
27. Goll, D.E., V.F. Thompson, R.G. Taylor, and T. Zalewska. 1992. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays. 14:549-556.
28. Hahn, K., R. DeBiasio, and D. Taylor. 1992. Patterns of elevated free calcium and calmodulin activation in living cells. Nature. 359:736-738.
29. Hartwig, J.H., G.M. Bokoch, C.L. Carpenter, P.A. Janmey, L.A. Taylor, A. Toker, and T.P. Stossel. 1995. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell. 82:643-653.
30. Henry, M.D., C. Gonzalez Agosti, and F. Solomon. 1995. Molecular dissection of radixin: Distinct and interdependent functions of the amino- and carboxy-terminal domains. J. Cell Biol. 129:1007-1022.
31. Herman, I.M. 1993. Actin isoforms. Curr. Opin. Cell Biol. 5:48-55.
32. Hill, M.A., and P. Gunning. 1993. Beta and gamma actin mRNA are differentially located within myoblasts. J. Cell Biol. 122:825-832.
33. Hoock, T.C., P.M. Newcomb, and I.M. Herman. 1991. β-actin and its mRNA are localized at the plasma membrane and the regions of moving cytoplasm during the cellular response to injury. J. Cell Biol. 112:653-664.
34. Huttenlocher, A., S.P. Palecek, Q. Lu, W. Zhang, R.L. Mellgren, D.A. Lauffenburger, M.H. Ginsberg, and A.F. Horowitz. 1997. Regulation of cell migration by the calcium-dependent protease calpain. J. Biol. Chem. 272:32719-32722.
35. Janmey, P.A. 1994. Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. Annu. Rev. Physiol. 56:169-191.
36. Kislauskis, E.H., Z. Li, R.H. Singer, and K.L. Taneja. 1993. Isoform-specific 3′-untranslated sequences sort α-cardiac and β-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J. Cell Biol. 123:165-172.
37. Kislauskis, E.H., X.-C. Zhu, and R.H. Singer. 1997. β-Actin messenger RNA localization and protein synthesis augment cell motility. J. Cell Biol. 136: 1263-1270.
38. Latham, V.M., Jr., E.H. Kislauskis, R.H. Singer, and A.F. Ross. 1994. β-Actin mRNA localization is regulated by signal transduction mechanisms. J. Cell Biol. 126:1211-1219.
39. Lauffenberger, D.A., and A.F. Horwitz. 1996. Cell migration: A physically integrated molecular process. Cell. 84:359-369.
40. Lee, W.J., H. Ma, E. Takano, H.Q. Yang, M. Hatanaka, and M. Maki. 1992. Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J. Biol. Chem. 267:8437-8442.
41. Lewis, J.M., D.A. Cheresh, and M.A. Schwartz. 1996. Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J. Cell Biol. 134:1323-1332.
42. Maki, M., M. Hatanaka, E. Takano, and T. Murachi. 1990. Structure-function Relationship of Calpastatins. In Intracellular Calcium-dependent Proteolysis. R.L. Mellgren and T. Murachi, editors. CRC Press, Boca Raton, FL. 37-54.
43. Marks, P., and F. Maxfield. 1990. Transient increases in cytosolic free calcium appear to be required for the migration of adherent human neutrophils. J. Cell Biol. 110:43-52.
44. 2-terminal domain inhibits the cell extension activity of the COOH-terminal domain. J. Cell Biol. 128:1081-1093.
45. Mehdi, S. 1991. Cell-penetrating inhibitors of calpain. Trends Biochem. Sci. 16: 150-153.
46. Mehdi, S., M.R. Angelastro, J.S. Wiseman, and P. Bey. 1988. Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpain. Biochem. Biophys. Res. Comm. 157:1117-1123.
47. Mellgren, R.L. 1997. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome. J. Biol. Chem. 272:29899-29903.
48. Mellgren, R.L., and R.D. Lane. 1990. The Regulation of Calpains by Interaction with Calpastatins. In Intracellular Calcium-Dependent Proteolysis. R.L. Mellgren and T. Murachi, editors. CRC Press, Boca Raton, FL. 115-127.
49. Mellgren, R.L., E. Shaw, and M.T. Mericle. 1994. Inhibition of growth of human TE2 and C-33A cells by the cell-permeant calpain inhibitor benzyloxycarbonyl-leu-leu-tyr diazomethyl ketone. Exp. Cell Res. 215:164-171.
50. Mellgren, R.L., Q. Lu, W. Zhang, M. Lakkis, E. Shaw, and M.T. Mericle. 1996. Isolation of a Chinese hamster ovary cell clone possessing decreased mucalpain content and a reduced proliferative growth rate. J. Biol. Chem. 271: 15568-15574.
51. 2+-requiring proteinase. Proc. Natl. Acad. Sci. USA. 82:6435-6439.
52. 2+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). Adv. Enzyme Regul. 19: 407-424.
53. Nath, R., K.J. Raser, D. Stafford, I. Hajimohammadreza, A. Posner, H. Allen, R. V. Talanian, P.-W. Yuen, R.B. Gilbertsen and K.K.W. Wang. 1996. Non-erythroid α-spectrin breakdown by calpain and interleukin 1β-converting enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319:683-690.
54. 2+-dependent neutral protease in rat liver. J. Biochem. 84: 1657-1659.
55. 2+-dependent neutral protease in rat brain. Experientia (Basel). 35: 1006-1007.
56. Norris, F.A., R.C. Atkins, and P.W. Majerus. 1997. Inositol polyphosphate 4-phosphatase is inactivated by calpain-mediated proteolysis in stimulated platelets. J. Biol. Chem. 272:10987-10989.
57. Nuckolls, G.H., L.H. Romer, and K. Burridge. 1992. Microinjcction of antibodies against talin inhibits the spreading and migration of fibroblasts. J. Cell Sci. 102:753-762.
58. Saito, K.-I., and R.A. Nixon. 1993. Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human μCANP and mCANP. Neurochem. Res. 18:231-233.
59. Sasaki, T., T. Kikuchi, N. Yumoto, N. Yoshimura, and T. Murachi, 1984. Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. J. Biol. Chem. 259:12489-12494.
60. Schafer, D.A., Y.O. Korshunova, T.A. Schroer, and J.A. Cooper. 1994. Differential localization and sequence analysis of capping protein β-subunit isoforms of vertebrates. J. Cell Biol. 127:453-465.
61. Schollmeyer, J.E. 1988. Calpain II involvement in mitosis. Science. 240:911-913.
62. Shaw, E. 1994. Peptidyl diazomethanes as inhibitors of cysteine and serine proteases. Methods Enzymol. 244:649-656.
63. Shuster, C.B. and I.M. Herman. 1995. Indirect association of ezrin with F-actin: Isoform specificity and calcium sensitivity. J. Cell Biol. 128:837-848.
64. Shuster, C.B., A.Y. Lin, R. Nayak, and I.M. Herman. 1996. βCAP73: A novel β actin-specific binding protein. Cell Motil. Cytoskel. 35:175-187.
65. Sorimachi, H., T.C. Saido, and K. Suzuki. 1994. New era of calpain research. Discovery of tissue-specific calpains. FEBS (Fed. Eur. Biochem. Soc.) Lett. 343:1-5.
66. Stossel, T.P. 1993. On the crawling of animal cells. Science. 260:1086-1094.
67. Takano, E., T. Nosaka, W.J. Lee, K. Nakamura, T. Takahashi, M. Funaki, H. Okada, M. Hatanaka, and M. Maki. 1993. Molecular diversity of calpastatin in human erythroid cells. Arch. Biochem. Biophys. 303:349-354.
68. Tsujinaka, T., Y. Kajiwara, J. Kambayashi, M. Sakon, N. Higuchi, T. Tanaka, and T. Mori. 1988. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Bichem. Biophys. Res. Comm. 153:1201-1208.
69. 1 integrin-mediated cell spreading on fibronectin. J. Biol. Chem. 268:21459-21462.
70. Wang, K.K.W., and P.-W. Yuen. 1994. Calpain inhibition: An overview of its therapeutic potential. Trends Pharm. Sci. 15:412-419.
71. Wang, K.K.W., and P.-W. Yuen. 1997. Development and therapeutic potential of calpain inhibitors. Adv. Pharm. 37:117-152.
72. Waxman, L., and E.G. Krebs. 1978. Identification of two protease inhibitors from bovine cardiac muscle. J. Biol. Chem. 253:5888-5891.
73. Welch, M.D., A. Mallavarapu, J. Rosenblatt, and T.J. Mitchison. 1997. Actin dynamics in vivo. Curr. Opin. Cell Biol. 9:54-61.
74. Winckler, B., C. Gonzalez Agosti, M. Magendantz, and F. Solomon. 1994. Analysis of a cortical cytoskeletal structure: a role for ezrin-radixin-moesin (ERM proteins) in the marginal band of chicken erythrocytes. J. Cell Sci. 107:2523-2534
75. Witke, W., A.H. Sharpe, J.H. Hartwig, T. Azuma, T.P. Stossel, and D.J. Kwiatkowski. 1995. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking geisolin. Cell. 81:41-51.
76. Yang, H.Q., H. Ma, E. Takano, M. Halanaka, and M. Maki. 1994. Analysis of calcium-dependent interaction between amino-terminal conserved region of calpastatin functional domain and calmodulin-like domain of mu-calpain large subunit. J. Biol. Chem. 269:18977-18984.
77. Yao, X., A. Thibodeau, and J.G. Forte. 1993. Ezrin-calpain I interactions in gastric parietal cells. Am. J. Physiol. 265:C36-C46.
78. Yao, X., C, Chaponnier, G. Gabbiani, and J.G. Forte. 1995. Polarized distribution of actin isoforms in gastric parietal cells. Mol. Biol. Cell. 6:541-557.
79. Yao, X., L. Cheng, and J.G. Forte. 1996. Biochemical characterization of ezrinactin interaction. J. Biol. Chem. 271:7224-7229.
80. Yokota, H., M. Katayama, F. Hino. I. Kato, E. Takano, M. Maki, M. Hatanaka, and T. Murachi. 1991. Direct measurement of calpastatin subtypes by sandwich enzyme immunoassay using monoclonal antibodies. Mol. Cell. Probes. 5:261-269.
81. 2+ proteases (calpain I and calpain II) purified concurrently by the same method from rat kidney. J. Biol. Chem. 258:8883-8889.
82. Zhang, W., R.D. Lane, and R.L. Mellgren. 1996. The major calpain isozymes are long-lived proteins. Design of an anti-sense strategy for calpain depletion in cultured cells. J. Biol. Chem. 271:18825-18830.